Sign up or log in to bookmark your favorites and sync them to your phone or calendar.

Psychosocial Academy Workshop - Half-Day (AM) [clear filter]
Tuesday, July 28


3: Acceptance and Commitment Therapy for Cancer Patients (Half-Day Workshop, AM)
Acceptance and Commitment Therapy for Cancer Patients and Survivors

Speaker: Dianne M. Shumay

Diagnosis with cancer brings significant challenges for survivors attempting to live full and meaningful lives in the face of fear, illness and pain. Acceptance and Commitment Therapy (ACT), a “third wave” behavior therapy, with its focus on mindfulness, flexible perspective taking, values and committed action seems particularly well-suited to helping cancer patients live their best possible lives. ACT has strong empirical support for addressing anxiety and other psychological and physical symptoms in healthy and medically ill populations, with new but growing evidence for effectiveness in cancer.This 4 hour highly interactive workshop will give a context for the clinical application of ACT for cancer patients and survivors, teach basic clinically-applicable skills in ACT, provide an overview of research evidence for ACT and describe a model manualized intervention and research plan for addressing anxiety in cancer survivors. Skill-building and role-play in small groups will be focused on analysis and intervention in mindful awareness, perspective- taking, acceptance, and making choices based on personal values, with experiential exercises and training in practical application to psycho-oncology settings. We will describe and demonstrate ACT-consistent ways to conceptualize psychological and physical symptoms and health-related behaviours for cancer patients and survivors. For those interested in research, we will share an overview of the evidence base and our own experience with launching a research program in ACT in cancer and facilitate an interactive discussion of concepts and research strategies.The attendee shall be able to:

  • Conceptualize psychological symptoms in terms of an ACT framework including experiential avoidance, fusion and perspective-taking.
  • Formulate an ACT-based intervention plan targeting mindful awareness, defusion, and clarification of personal values.
  • Describe the research evidence for ACT in cancer and a model for researching interventions for ACT in cancer.

Tuesday July 28, 2015 8:01am - 12:00pm
Union Station Meeting Level 3


7: Treating Body Image Concerns of Cancer Patients (Half-Day Workshop, AM)
Treating Body Image Concerns of Cancer Patients: Latest Advancements in Science and Clinical Practice

Speakers: Erin Buck PhD, Irene Teo PhD and Michelle Fingeret PhD

This 4 hour workshop will be delivered by psychologists working in the United States and Singapore who have unique expertise in conducting research and clinical care for cancer patients adjusting to body image changes that result from cancer and its treatment. We seek to provide a general overview of theoretical and conceptual foundations for managing body image changes experienced by cancer survivors and introduce attendees to several internationally recognized programs that have fueled major advancements in research, clinical practice, and public policy related to body image care for cancer patients. The majority of the workshop will be focused on training psychosocial providers how to develop and deliver empirically-supported body image interventions to enhance patient care. A broad range of treatment strategies will be covered including the use of cognitive-behavioral therapy, mindfulness, motivational, and acceptance-based approaches. We will also demonstrate ways that body image interventions developed with cancer patients at a large comprehensive cancer center in the United States have been applied and modified for use with cancer patients at the National Cancer Centre in Singapore. This will provide a unique opportunity to consider cross-cultural issues in body image care.

Learning Objectives:

  1. Describe 3 theoretical models providing a foundation for empirically-supported intervention strategies to treat body image difficulties of cancer survivors
  2. Delineate numerous practical intervention strategies to help cancer patients cope with recent body image changes and promote greater body image acceptance during survivorship
  3. Identify cultural issues affecting the delivery of body image care to cancer survivors in different parts of the world

Tuesday July 28, 2015 8:01am - 12:00pm
Judiciary Square Meeting Level 3


8: eHealth Development and Implementation of Internet interventions in Psycho-Oncology (Half-Day Workshop, AM)
eHealth Development and Implementation of Internet Interventions in Psycho-Oncology

Speakers: Lee Ritterband, PhD

The Internet is now a vital resource to hundreds of millions of people around the world, and its uses seem limitless. However, nowhere does it seem more useful than in the health care field. One area, in particular, where the integration and utilization of the Internet has skyrocketed is as a tool to deliver behavioral and psycho-social based interventions. These Internet interventions are usually derived from effective face-to-face treatments that have been operationalized and transformed for Internet delivery. They are often highly structured, but personalized and tailored to the individual user. They can be deployed as self or semi-self-guided programs, and most are interactive and enhanced with the multimedia capabilities of the Web.

Making behavioral/psychosocial/mental health treatment and prevention programs widely available on the Internet has obvious appeal. Delivering care in this way can help overcome many of the traditional barriers to providing care, including inadequate treatment access, limited trained clinicians, poor geographical distribution of knowledgeable professionals, and expense. They clearly have promise as an efficacious, scalable, and cost effective prevention and treatment option with significant public health impact. Furthermore, interventions can be delivered in a standardized manner with fidelity across a variety of settings. Outcome trials of Internet interventions have consistently demonstrated significant changes in behavior and meaningful symptom improvements.

This workshop will begin with a brief history (and end with a discussion of the considerable future) of Internet interventions. Similarities of Internet interventions will be presented, while also highlighting the substantial variations among programs, and differences between them and more typical websites. Information regarding the use of theory and behavior change models to guide Internet intervention development will be reviewed. Several cancer focused Internet interventions will be shown in more detail as examples. Program features will be demonstrated and outcomes from clinical trials will be highlighted. Finally, attendees will have an opportunity to work as part of a small group on creating elements of an Internet intervention. This hands-on experience will utilize a developed flexible platform for developing and implementing these type of programs.The attendee shall be able to:
  1. Define and identify Internet interventions, particularly as they compare with other types of websites.
  2. Appreciate the underlying theoretical foundations of Internet interventions and how eHealth programs can lead to behavior change and symptom improvements.
  3. Leave with some hands-on experience in utilizing a flexible framework for developing an Internet intervention.
  4. Understand the current potential of eHealth interventions and some possible future directions of the field.
Workshop attendees are strongly encouraged to bring their own laptop to this session, as there will be some hands on opportunities.

Tuesday July 28, 2015 8:01am - 12:00pm
DuPont Circle Meeting Level 3
Wednesday, July 29


16: Cancer Control and Predictive Genetic Testing Among Youth (Half-Day Workshop, AM)
Cancer Control and Predictive Genetic Testing Among Youth:The Ethical, Legal and Social Issues (ELSI), and Health Promotive Opportunities

Speakers: Angela Bradbury MD, Dava Szalda MD, Linda Patrick-Miller PhD and Lisa A. Schwartz PhD

With advances in cancer predisposition genetics and cancer treatment, and better understanding of familial and genetic risk, the number of youth with identified risk for future cancer is increasing. It is known that familial patterns of cancer and/or genetic susceptibility confer risk to offspring. In addition, cancer survivors are at higher risk of secondary malignant neoplasms as a result of the carcinogenic treatment to cure their first cancer, or an underlying genetic predisposition. At the same time, there is increasing evidence that adolescence is a key period of carcinogenic vulnerability that health behaviors might alter. Furthermore guidelines suggest screening should be tailored to individual risk. As such, there is a need for health care professionals to understand the current state of the science and policy with regards to cancer control and genetic testing in order to help families and youth understand and navigate their cancer risk.

The workshop will use breast cancer risk as our primary example. Young women with genetic predisposition, known family history of breast cancer, and history of previous malignancy are at higher risk for developing breast cancer in adulthood. Long-term surveillance is less than optimal for young adults at high risk, which is likely attributable to many psychosocial and systems factors. Although current U.S. guidelines recommend delaying testing for adult onset cancers, e.g. BRCA1/2 mutations, until adulthood, there has been ongoing debate over the associated ethical, legal and social issues (ELSI) in BRCA1/2 families. There are many challenges and questions related to how best to communicate, manage and counsel these patients and families during the transition to adulthood prior to the onset of regular surveillance with breast imaging. Furthermore, there is growing evidence of risk and protective factors, many of which are controllable, related to future breast cancer risk that can be addressed in adolescence. Thus, breast cancer is an exemplar cancer with which to highlight the nuances and challenges of facilitating and providing appropriate risk-based care and surveillance.

Using breast cancer as our primary example, we will provide an overview of the current state of the science related to cancer susceptibility, including genetic testing, with particular emphasis on implications for youth. Topics of discussion will include: 1) US guidelines and policy and how they might differ from other international standards and practices, 2) ethical, legal and social (ELSI) Issues, 3) counseling on health promotion, genetic testing, and surveillance; 4) appropriate referrals for multidisciplinary care 5) communication with parents, patients, and adult providers, 6) and related issues when transferring adolescent and young adult patients to adult care. The workshop will combine didactics, review of cases, and small and large group discussion. The workshop leaders represent clinical and research expertise in pediatric and medical oncology, adolescent medicine, pediatric and adult clinical health psychology, medical ethics, and cancer control and health promotion.

  • Describe current state of the science related to cancer susceptibility and control among youth using breast cancer as an example.
  • Describe the ethical legal and social issues (ELSI) related to genetic testing in minors.
  • Describe current US guidelines and practices related to genetic testing and breast cancer prevention among adolescents and young adults and potential for international differences.
  • Describe approaches to anticipatory guidance and counseling about cancer risk and cancer control for adolescents and young adults.

Wednesday July 29, 2015 8:00am - 12:00pm
Capitol Hill Meeting Level 3


17: Why Do I Need To Know About Psychiatric Medications? (Half-Day Workshop, AM)
Why Do I Need to Know About Psychiatric Medications? I'm Not a Prescriber!
- Because You Have the Opportunity to Save Your Patient's Life

Speakers: Andrew Roth, MD, Philip Bailer, MD and Steven Passik, PhD

Clinicians have numerous tools at their disposal to help adult cancer patients dealing with symptoms of depression, anxiety, and other cancer sequelae. Psychiatric medications are most frequently prescribed to cancer patients by oncologists and general practitioners, however psychiatric syndromes are often underdiagnosed and undertreated. Few oncology practices have dedicated psychiatric consultants familiar with the nuances of Psycho-Oncology. Even when patients receive psychotropic medications appropriately, they may have problems that arise before their next Oncology visit or before they see the person who prescribed their psychiatric medications. Psychologists, nurses and social workers play an essential role in identifying psychological and physical symptoms as well as both beneficial and problematic medication effects as they provide frontline psychosocial interventions and support for cancer patients.

This workshop is designed for the non-prescribing psycho-oncology clinician as well as the psychiatrist who is new to the world of Psycho-pharmaco-oncology. The workshop will focus on key target symptoms amenable to psychopharmacological intervention, including anxiety, depression, insomnia, pain, fatigue and anorexia. Precipitants will learn to identify psychological reactions to medical conditions or treatments; psychiatric presentations of medical conditions or treatments; medical presentations of psychiatric conditions and common medical complications of psychiatric conditions or treatments. 

Basic information will be presented about medications used to alleviate QOL symptoms that arise in the cancer setting from diagnosis to survivorship or end of life care, and the interface of psychotherapy and medication management. 

We will review why certain medications are used and why some are avoided, looking at potential benefits, unwanted side effects, and drug-drug interactions, since you may be the first person to identify a serious adverse event. The workshop will also enhance your ability to provide psychoeducation to patients regarding psychiatric medications.

The following classes of medications will be covered in this workshop: antidepressants, anxiolytics/hypnotics, antipsychotics, mood stabilizers, and psychostimulants. Case vignettes will be used to illustrate how to formulate an appropriate and effective medication regimen in a cancer patient struggling with a complex cancer-related symptom burden. Plenty of time will be allowed for questions and discussion, and handouts will be provided for the audience.

Learning Objectives:
  1. Psychotropic non-prescribers and junior psychiatrists will learn how to hone essential clinical and observation skills to improve the quality of life, mental health and safety of their patients by understanding the basics of the psychophysiology of cancer. Participants will learn about new technologies, such as Urine Drug Testing (UDT) and Pharmaco-Genetic Testing (PGT), which will help them be even more a part of multidisciplinary oncology teams.
  2. Participants will learn basic psycho-pharmaco-oncology including how to think about better and worse choices of psychotropics, as well as how to identify problematic side effects to transmit to the oncology team before the patient’s next visit with the oncology team.

Wednesday July 29, 2015 8:00am - 12:00pm
DuPont Circle Meeting Level 3